Antineoplastic activities of Gd@C82(OH)22 nanoparticles: Tumor microenvironment regulation

Science China Life Sciences

Volumn 55, Issue 10, 2012, Pages 884-890

  Li, YiYe ^a   Tian, YanHuan ^a,b   Nie, GuangJun ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

antineoplastic nanoparticles; Gd@C82(OH)22; tumor microenvironment

Indexed keywords

CARBON; GADOLINIUM; NANOPARTICLE;

CHEMISTRY; HUMAN; REVIEW; TUMOR MICROENVIRONMENT;

CARBON; GADOLINIUM; HUMANS; NANOPARTICLES; TUMOR MICROENVIRONMENT;

EID: 84868371150     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-012-4387-7     Document Type: Review

References (24)

1. Bissell M J, Radisky D. Putting tumours in context. Nat Rev Cancer, 2001, 1: 46.
2. Bissell M J, Hines W C. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med, 2011, 17: 320-329.
3. Avastin (bevacizumab) Information. U. S. Food and Drug Adminis-tration. http://www. fda. gov/Drugs/DrugSafety/Postmarket-DrugSafety-InformationforPatientsandProviders/ucm193900. htm.
4. Yan L, Zhao F, Li S F, et al. Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes. Nanoscale, 2011, 3: 362-382.
5. Qu L, Cao W B, Xing G M, et al. Study of rare earth encapsulated carbon nanomolecules for biomedical uses. J Alloy Compd, 2006, 408/412: 400-404.
6. Xing G M, Yuan H, He R, et al. The strong MRI relaxivity of paramagnetic nanoparticles. J Phys Chem B, 2008, 112: 6288-6291.
7. n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett, 2005, 5: 2050-2057.
8. Yin J J, Lao F, Fu P P, et al. The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials. Biomaterials, 2009, 30: 611-621.
9. Meng H, Xing G M, Sun B Y, et al. Potent angiogenesis inhibition by the particulate form of fullerene derivatives. ACS Nano, 2010, 4: 2773-2783.
10. n nanoparticles in tumor-bearing mice. Biochem Pharmacol, 2006, 71: 872-881.
11. 22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunity. Biomaterials, 2009, 30: 3934-3945.
12. n nanoparticles induce dendritic cell maturation and activate Th1 immune responses. ACS Nano, 2010, 4: 1178-1186.
13. Meng H, Xing G, Blanco E, et al. Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells. Nanomedicine: NBM, 2012, 8: 136-146.
14. Tang J, Xing G, Yuan H, et al. Tuning electronic properties of metallic atom in bondage to a nanospace. J Phys Chem B, 2005, 109: 8779-8785.
15. Tang J, Xing G, Zhao Y, et al. Periodical variation of electronic properties in polyhydroxylated metallofullerene materials. Adv Mater, 2006, 18: 1458-1462.
16. 82 by ICP-MASS. J Radioanal Nucl Chem, 2007, 272: 537-540.
17. Tang J, Xing G M, Zhao F, et al. Modulation of structural and electronic properties of fullerene and metallofullerenes by surface chemical modifications. J Nanosci Nanotechnol, 2007, 7: 1085-1101.
18. 82-Polystyrene. J Phys Chem C, 2010, 114: 7631-7636.
19. 82(OH)x studied by synchrotron radiation XPS. J Radioanal Nucl Chem, 2007, 272: 307-310.
20. Tang J, Xing G, Zhao Y, et al. Switchable semiconductive property of the polyhydroxylated metallofullerene. J Phys Chem B, 2007, 111: 11929-11934.
21. 82 on Cu(111) and Cu(100). J Phys Chem C, 2011, 115: 6265-6268.
22. 22 nanoparticles on Caenorhabditis elegans. Nanoscale, 2011, 3: 2636-2641.
23. Yin J J, Lao F, Meng J, et al. Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger. Mol Pharmacol, 2008, 74: 1132-1140.
24. Liang X J, Meng H, Wang Y, et al. Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc Natl Acad Sci USA, 2010, 107: 7449-7454.